Onconova Therapeutics, Inc. Closes $21 Million Public Offering of Common Stock
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX) announced the recent closing of its previously announced underwritten public offering.
Read MorePublic offering
Onconova Therapeutics Announces Proposed Public Offering of Common Stock
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX) recently announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the …
Read More
Century Therapeutics Announces Pricing of Initial Public Offering
PHILADELPHIA, PA — Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, recently announced the pricing of its initial public offering of 10,550,000 …
Read More
Aclaris Announces Pricing of Public Offering of Common Stock
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced the pricing of its underwritten public …
Read More Aclaris Announces Proposed Public Offering of Common Stock
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced that it intends to offer and …
Read More
UGI Prices Equity Units Offering
VALLEY FORGE, PA — UGI Corporation (NYSE: UGI) announced the pricing of its public offering of 2,000,000 equity units. The issuance and sale of the units are scheduled to settle …
Read More
Recro Announces Pricing of $30.0 Million Public Offering of Common Stock
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read More Recro Announces Proposed Public Offering of Common Stock
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read More
PQ Group Holdings Announces Pricing of Secondary Offering
MALVERN, PA — PQ Group Holdings Inc. (NYSE: PQG) yesterday announced the pricing of the previously announced underwritten public offering by certain of its stockholders of 12,500,000 shares of its …
Read More
AmerisourceBergen Closes Public Offering
VALLEY FORGE, PA — AmerisourceBergen Corporation (NYSE: ABC) recently announced the closing of this week’s public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, …
Read More